FundedIQ
Biotechnology

Purigen Biosystems: Funding, Investors & Team (Sep 2026)

Purigen Biosystems' innovative products offer a truly transformative solution for DNA and RNA purification. Their proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, their technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Their Ionic Purification System and Kits combine to provide researchers with a fast, efficient, and effective alternative for automated nucleic acid purification.

www.purigenbio.com LinkedIn Pleasanton, United States 11-50 employees
Total raised
$34.4M
Rounds
1
Latest
Undisclosed round
Apr 2021

Purigen Biosystems has raised $34.4M across 1 funding round on record, the most recent an undisclosed round of $34.4M announced in Apr 2021.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Purigen Biosystems Company Profile and Key Stats

Total funding raised
$34.4M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$34.4M in Apr 2021
Employees
11-50
reported band
Headquarters
Pleasanton, United States

Latest funding round on record: Apr 2021.

Purigen Biosystems Funding Rounds

Date
Round
Amount
Undisclosed round
$34.4M

Purigen Biosystems Founders and Leadership Team

Name
Role
Contact
Barney Saunders
CEO
Locked

Contact details for the Purigen Biosystems team: 1 of 1 has an email address on file.

Start 14-day free trial →

Purigen Biosystems Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Purigen Biosystems' latest round of $34.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Purigen Biosystems in Biotechnology and Pleasanton

Companies Similar to Purigen Biosystems

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Purigen Biosystems Funding FAQs

What does Purigen Biosystems do?

Purigen Biosystems' innovative products offer a truly transformative solution for DNA and RNA purification. Their proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, their technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Their Ionic Purification System and Kits combine to provide researchers with a fast, efficient, and effective alternative for automated nucleic acid purification.

How much funding has Purigen Biosystems raised?

Purigen Biosystems has raised $34.4M across 1 round on record. The most recent is an undisclosed round of $34.4M announced in Apr 2021.

When did Purigen Biosystems last raise funding?

Purigen Biosystems' most recent funding round on record is an undisclosed round of $34.4M, announced in Apr 2021.

Who is the CEO of Purigen Biosystems?

Barney Saunders is listed as CEO at Purigen Biosystems.

Where is Purigen Biosystems headquartered?

Purigen Biosystems is based in Pleasanton, California, United States.

How many employees does Purigen Biosystems have?

Purigen Biosystems is in the 11-50 employee band.

How does Purigen Biosystems' funding compare to other Biotechnology startups?

Purigen Biosystems' latest round of $34.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Purigen Biosystems Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Purigen Biosystems is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.